TEVA PHARMACEUTICAL INDUSTRIES LTD Annual Return On Equity in % from 2010 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Teva Pharmaceutical Industries Ltd quarterly/annual Return On Equity history and growth rate from 2010 to 2023.
  • Teva Pharmaceutical Industries Ltd Return On Equity for the quarter ending September 30, 2024 was -13.4 %, a 53.8% increase year-over-year.
  • Teva Pharmaceutical Industries Ltd annual Return On Equity for 2023 was -7.07 %, a 72.4% increase from 2022.
  • Teva Pharmaceutical Industries Ltd annual Return On Equity for 2022 was -25.6 %, a 791% decline from 2021.
  • Teva Pharmaceutical Industries Ltd annual Return On Equity for 2021 was 3.71 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -7.07 +18.6 +72.4% Jan 1, 2023 Dec 31, 2023
2022 -25.6 -29.3 -791% Jan 1, 2022 Dec 31, 2022
2021 3.71 +35 Jan 1, 2021 Dec 31, 2021
2020 -31.3 -24.7 -378% Jan 1, 2020 Dec 31, 2020
2019 -6.54 +5.02 +43.4% Jan 1, 2019 Dec 31, 2019
2018 -11.6 +45.3 +79.7% Jan 1, 2018 Dec 31, 2018
2017 -56.9 -57.9 -5918% Jan 1, 2017 Dec 31, 2017
2016 0.98 -5.47 -84.9% Jan 1, 2016 Dec 31, 2016
2015 6.44 -6.61 -50.7% Jan 1, 2015 Dec 31, 2015
2014 13.1 +7.37 +130% Jan 1, 2014 Dec 31, 2014
2013 5.67 -2.86 -33.5% Jan 1, 2013 Dec 31, 2013
2012 8.53 -3.44 -28.7% Jan 1, 2012 Dec 31, 2012
2011 12 -4.13 -25.7% Jan 1, 2011 Dec 31, 2011
2010 16.1 Jan 1, 2010 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.